711 related articles for article (PubMed ID: 7627978)
21. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
22. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
23. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
Subklewe M; Sebelin K; Block A; Meier A; Roukens A; Paludan C; Fonteneau JF; Steinman RM; Münz C
Hum Immunol; 2005 Sep; 66(9):938-49. PubMed ID: 16360833
[TBL] [Abstract][Full Text] [Related]
26. Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells.
Orsini DL; van Gils M; Kooy YM; Struyk L; Klein G; van den Elsen P; Koning F
Eur J Immunol; 1994 Dec; 24(12):3199-204. PubMed ID: 7528674
[TBL] [Abstract][Full Text] [Related]
27. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease.
Dukers DF; Jaspars LH; Vos W; Oudejans JJ; Hayes D; Cillessen S; Middeldorp JM; Meijer CJ
J Pathol; 2000 Feb; 190(2):143-9. PubMed ID: 10657011
[TBL] [Abstract][Full Text] [Related]
28. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
[TBL] [Abstract][Full Text] [Related]
29. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
[TBL] [Abstract][Full Text] [Related]
30. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
Aya T; Mizuno F; Osato T
J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
[TBL] [Abstract][Full Text] [Related]
31. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
[TBL] [Abstract][Full Text] [Related]
32. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
[TBL] [Abstract][Full Text] [Related]
33. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
Wang EC; Lehner PJ; Graham S; Borysiewicz LK
Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
[TBL] [Abstract][Full Text] [Related]
34. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease.
Frisan T; Sjöberg J; Dolcetti R; Boiocchi M; De Re V; Carbone A; Brautbar C; Battat S; Biberfeld P; Eckman M
Blood; 1995 Aug; 86(4):1493-501. PubMed ID: 7632957
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
36. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines.
Fishwild DM; Benike CJ; Engleman EG
J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276
[TBL] [Abstract][Full Text] [Related]
37. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
[TBL] [Abstract][Full Text] [Related]
39. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
40. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]